Management of pregnancy in type 3 von Willebrand disease with alloantibodies. - Suppr | 超能文献

Management of pregnancy in type 3 von Willebrand disease with alloantibodies.

作者信息

Scott Martin, Hay Charles R M, Elkhalifa Shuayb, Tower Clare, Cocker Michael, Thachil Jecko

机构信息

University Department of Haematology, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK.

Institute of Cancer Sciences, The University of Manchester, Manchester, UK.

出版信息

Br J Haematol. 2018 Aug;182(3):440-442. doi: 10.1111/bjh.14805. Epub 2017 Jul 12.

DOI:10.1111/bjh.14805

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Management of pregnancy in type 3 von Willebrand disease with alloantibodies.

Br J Haematol. 2018 Aug;182(3):440-442. doi: 10.1111/bjh.14805. Epub 2017 Jul 12.

2

Continuous infusion of recombinant factor VIIa (NovoSeven) in the treatment of a patient with type III von Willebrand's disease and alloantibodies against von Willebrand factor.重组凝血因子VIIa（诺其）持续输注治疗III型血管性血友病并伴有血管性血友病因子同种抗体的患者。

Thromb Haemost. 2000 Apr;83(4):633-4.

3

The use of recombinant activated factor VII in congenital and acquired von Willebrand disease.重组活化凝血因子 VII 在先天性和获得性血管性血友病中的应用。

Blood Coagul Fibrinolysis. 2006 Nov;17(8):615-9. doi: 10.1097/MBC.0b013e3280100d1e.

4

Use of recombinant factor VIIa (NovoSeven) in the treatment of two patients with type III von Willebrand's disease and an inhibitor against von Willebrand factor.重组凝血因子VIIa（诺其）用于治疗两名III型血管性血友病患者及一种血管性血友病因子抑制剂。

Haemostasis. 1996;26 Suppl 1:150-4. doi: 10.1159/000217258.

5

Management of delivery with FVIII/VWF concentrates in a pregnant woman with type 3 von Willebrand disease and alloantibodies.

Thromb Haemost. 2012 Oct;108(4):796-8. doi: 10.1160/TH12-03-0136. Epub 2012 Jul 26.

6

Successful treatment with recombinant factor VIIa of therapy-resistant severe bleeding in a patient with acquired von Willebrand disease.重组凝血因子VIIa成功治疗一名获得性血管性血友病患者的难治性严重出血。

Am J Hematol. 2001 Apr;66(4):292-4. doi: 10.1002/ajh.1060.

7

Antibodies to von Willebrand factor in von Willebrand disease.血管性血友病中血管性血友病因子抗体

Adv Exp Med Biol. 1995;386:87-92. doi: 10.1007/978-1-4613-0331-2_7.

8

Gene deletions correlate with the development of alloantibodies in von Willebrand disease.基因缺失与血管性血友病中同种抗体的产生相关。

J Clin Invest. 1987 May;79(5):1459-65. doi: 10.1172/JCI112974.

9

Mapping and functional studies of two alloantibodies developed in patients with type 3 von Willebrand disease.对3型血管性血友病患者体内产生的两种同种抗体的图谱绘制及功能研究。

Thromb Haemost. 2000 Feb;83(2):274-81.

10

Characterization of partial gene deletions in type III von Willebrand disease with alloantibody inhibitors.伴有同种抗体抑制剂的III型血管性血友病中部分基因缺失的特征分析。

Thromb Haemost. 1994 Aug;72(2):180-5.

引用本文的文献

1

Navigating the challenges: a case report on managing a complicated postpartum course in type 3 von Willebrand disease with alloantibodies.应对挑战：一例关于管理伴有同种抗体的3型血管性血友病复杂产后病程的病例报告

Res Pract Thromb Haemost. 2024 Apr 3;8(3):102399. doi: 10.1016/j.rpth.2024.102399. eCollection 2024 Mar.

2

How I manage severe von Willebrand disease.我是如何管理严重的血管性血友病的。

Br J Haematol. 2019 Nov;187(4):418-430. doi: 10.1111/bjh.16186. Epub 2019 Sep 9.